CWWBF (Plant Based Investment) Selling, General, & Admin. Expense: $1.45 Mil (TTM As of Jul. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Plant Based Investment Selling, General, & Admin. Expense?

Plant Based Investment CWWBF -90.00% Selling, General, & Admin. Expense is $1.45 Mil as of Jul. 2022.

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Plant Based Investment's selling, general, & admin. expense for the three months ended in Jul. 2022 was $0.30 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Jul. 2022 was $1.45 Mil.


Plant Based Investment  (OTCPK:CWWBF) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Plant Based Investment Selling, General, & Admin. Expense Related Terms


Plant Based Investment Selling, General, & Admin. Expense Historical Data

* Premium members only.

The historical data trend for Plant Based Investment's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Plant Based Investment Selling, General, & Admin. Expense Chart

Plant Based Investment Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21
Selling, General, & Admin. Expense
0.00 0.64 1.26 1.05 2.20

Plant Based Investment Quarterly Data
Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 0.56 0.30 0.28 0.30

CWWBF vs ZTS, CTLT, VTRS: Selling, General, & Admin. Expense Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Plant Based Investment's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Plant Based Investment Selling, General, & Admin. Expense vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Plant Based Investment's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Plant Based Investment's Selling, General, & Admin. Expense falls into.



Plant Based Investment Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Jul. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Selling, General, & Admin. Expense of $1.45 Mil mean?
Plant Based Investment (CWWBF) has a Selling, General, & Admin. Expense of $1.45 Mil as of Jul. 2022. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Plant Based Investment and its competitors.
Is Plant Based Investment's Selling, General, & Admin. Expense too high?
Plant Based Investment's current Selling, General, & Admin. Expense is $1.45 Mil.
How does Plant Based Investment's Selling, General, & Admin. Expense compare to ZTS and CTLT?
Plant Based Investment's Selling, General, & Admin. Expense of $1.45 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Drug Manufacturers company?
A good Selling, General, & Admin. Expense depends on the Drug Manufacturers industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Plant Based Investment and its competitors. Plant Based Investment's current Selling, General, & Admin. Expense is $1.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Plant Based Investment stock overvalued right now?
Plant Based Investment (CWWBF) has a current Selling, General, & Admin. Expense of $1.45 Mil. The current Selling, General, & Admin. Expense is $1.45 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For Plant Based Investment (CWWBF), the current Selling, General, & Admin. Expense is $1.45 Mil as of Jul. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Plant Based Investment Business Description

Address 240 Richmond Street West, Suite 4164, Toronto, ON, CAN, M5V1V6
Plant Based Investment Corp is an investment corporation that seeks to provide shareholders long-term total returns through capital appreciation and periodic distributions by investing in an actively managed portfolio of securities in public and private companies that derive a portion of their revenues, earnings or intellectual property-based value from products, equipment, services and/or technologies related to plant-based industries, including the cannabis plant family and its various compounds, the fungi industry (including medicinal, functional and psychedelics), super-foods and/or organic ingredients industries in addition to investing in specialty retail locations, functional medicine and wellness-based clinics and treatment centers.